Your browser is no longer supported. Please, upgrade your browser.
Settings
AGTC Applied Genetic Technologies Corporation daily Stock Chart
AGTC [NASD]
Applied Genetic Technologies Corporation
Index- P/E- EPS (ttm)-1.06 Insider Own0.40% Shs Outstand24.82M Perf Week15.42%
Market Cap141.23M Forward P/E- EPS next Y-1.65 Insider Trans-44.19% Shs Float21.52M Perf Month-31.03%
Income-19.20M PEG- EPS next Q-0.58 Inst Own47.10% Short Float3.87% Perf Quarter102.49%
Sales24.20M P/S5.84 EPS this Y90.90% Inst Trans6.74% Short Ratio0.62 Perf Half Y91.58%
Book/sh3.30 P/B1.72 EPS next Y31.20% ROA-21.40% Target Price15.93 Perf Year69.85%
Cash/sh2.52 P/C2.26 EPS next 5Y- ROE-26.10% 52W Range2.52 - 10.42 Perf YTD25.88%
Dividend- P/FCF- EPS past 5Y37.20% ROI-5.60% 52W High-47.70% Beta2.88
Dividend %- Quick Ratio4.30 Sales past 5Y105.80% Gross Margin- 52W Low116.27% ATR0.70
Employees85 Current Ratio4.30 Sales Q/Q-57.60% Oper. Margin-88.20% RSI (14)46.90 Volatility5.86% 10.86%
OptionableYes Debt/Eq0.00 EPS Q/Q-105.50% Profit Margin-79.50% Rel Volume0.67 Prev Close5.69
ShortableYes LT Debt/Eq0.00 EarningsFeb 13 Payout- Avg Volume1.35M Price5.45
Recom1.70 SMA20-11.52% SMA50-1.19% SMA20036.48% Volume241,480 Change-4.22%
Jan-28-20Initiated ROTH Capital Buy
Jan-27-20Initiated ROTH Capital Buy
Sep-27-19Upgrade BMO Capital Markets Market Perform → Outperform $5 → $9
Sep-27-19Reiterated H.C. Wainwright Buy $12 → $18
Sep-06-19Initiated Janney Buy $13
Sep-14-17Reiterated Stifel Buy $15 → $12
May-11-17Reiterated Stifel Buy $18 → $15
Mar-15-17Initiated Rodman & Renshaw Buy $16
Nov-09-16Upgrade ROTH Capital Neutral → Buy
Nov-09-16Reiterated Wedbush Outperform $20 → $17
Sep-13-16Reiterated Wedbush Outperform $36 → $20
Sep-13-16Reiterated Stifel Buy $29 → $24
Sep-13-16Downgrade Wells Fargo Outperform → Market Perform
Sep-13-16Downgrade ROTH Capital Buy → Neutral
Sep-13-16Downgrade Cantor Fitzgerald Buy → Hold
Feb-09-16Reiterated Stifel Buy $32 → $29
Dec-04-15Initiated Wells Fargo Outperform
Jul-22-15Initiated Chardan Capital Markets Buy $25
Jul-06-15Reiterated Cantor Fitzgerald Buy $28 → $32
Nov-13-14Reiterated Stifel Buy $29 → $31
Feb-19-20 07:00AM  AGTC Announces Completion of Enrollment in the Two Highest Dose Groups of its Ongoing Phase 1/2 Clinical Trial in Patients with X-Linked Retinitis Pigmentosa GlobeNewswire
Feb-16-20 08:50AM  2 Strong Buy Healthcare Stocks with Over 100% Upside Potential TipRanks
Feb-06-20 08:06PM  AGTC Announces Pricing of $32,500,000 Public Offering of Common Stock GlobeNewswire -18.54%
07:47AM  The Daily Biotech Pulse: Tonix Slumps On Failed Study, Applied Genetic Announces Offering, Beam Therapeutics, PPD Price IPOs Benzinga
Feb-05-20 04:36PM  AGTC Announces Proposed Public Offering of Common Stock GlobeNewswire +8.85%
Jan-28-20 07:30AM  Otonomy Presents Preclinical Results for GJB2 Gene Therapy Collaboration and Cisplatin Otoprotection Program GlobeNewswire -7.51%
Jan-23-20 07:00AM  AGTC Reports Encouraging Interim Six-Month Data from the Dose Escalation Cohorts of its Ongoing Phase 1/2 Clinical Trials in Achromatopsia GlobeNewswire -15.11%
Jan-22-20 04:01PM  AGTC to Host Conference Call and Webcast on January 23 at 8:00 am ET to Discuss Achromatopsia Interim Six-Month Data from the Dose Escalation Cohorts of its Ongoing CNGB3 and CNGA3 Phase 1/2 Clinical Trials GlobeNewswire +19.52%
Jan-21-20 07:00AM  AGTC Announces Agenda for R&D Day on January 28, 2020 in New York GlobeNewswire
Jan-10-20 10:08AM  Applied Genetic Stock Up on Favorable Eye Therapy Study Data Zacks -15.43%
09:08AM  Company News for Jan 10, 2020 Zacks
09:07AM  Implied Volatility Surging for Applied Genetic Technologies (AGTC) Stock Options Zacks
07:13AM  The Daily Biotech Pulse: Positive Data Readouts To Spur Aclaris, Moderna And Ultragenyx Benzinga
04:58AM  The Applied Genetic Technologies (NASDAQ:AGTC) Share Price Has Gained 190%, So Why Not Pay It Some Attention? Simply Wall St.
Jan-09-20 10:02AM  Applied Genetic Shares Rip Higher After Eye Disorder Gene Therapy Aces Midstage Trial Benzinga +122.84%
08:39AM  The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, DBV Announces Positive Peanut Allergy Study Findings, Applied Genetic Soars On Trial Results Benzinga
08:34AM  Applied Genetic Technologies' stock rockets on early-stage eye therapy data MarketWatch
07:00AM  AGTC Reports Positive Six-Month Data from its Ongoing Phase 1/2 Clinical Trial in X-Linked Retinitis Pigmentosa GlobeNewswire
Jan-08-20 04:01PM  AGTC to Host Conference Call and Webcast on January 9 at 8:00 am ET to Discuss X-Linked Retinitis Pigmentosa Interim Six-Month Data from the Dose Expansion Cohort of its Ongoing Phase 1/2 Clinical Trial GlobeNewswire
Dec-19-19 09:17AM  Biotech Stocks Are In a Position to Break Out in 2020, Analysts Say Barrons.com +7.64%
Dec-17-19 07:36PM  Is Applied Genetic Technologies Corp (AGTC) A Good Stock To Buy? Insider Monkey
Dec-04-19 08:19PM  Edited Transcript of AGTC earnings conference call or presentation 12-Nov-19 9:30pm GMT Thomson Reuters StreetEvents +9.03%
Dec-03-19 07:59AM  The Daily Biotech Pulse: Astellas To Buy Audentes For $3B, Applied Genetics Chief Medical Officer Quits, Axsome Aces Midstage Trial Benzinga
Dec-02-19 04:35PM  AGTC Announces Departure of Chief Medical Officer, Company on Track to Announce XLRP and ACHM Data in January 2020 GlobeNewswire
Nov-12-19 05:55PM  Applied Genetic Technologies (AGTC) Reports Q1 Loss, Lags Revenue Estimates Zacks
04:01PM  AGTC Announces Financial Results and Business Update for the Quarter Ended September 30, 2019 GlobeNewswire
Nov-06-19 07:00AM  AGTC to Host First Quarter Results Conference Call and Webcast on November 12, 2019 GlobeNewswire -7.74%
Nov-05-19 07:00AM  AGTC Announces Stargardt Disease as its Second Preclinical Ophthalmology Program and Reports Compelling Preclinical Data Supporting the Potential of its Dual-Vector Technology GlobeNewswire
Oct-31-19 06:38AM  We Think Applied Genetic Technologies (NASDAQ:AGTC) Can Afford To Drive Business Growth Simply Wall St.
Oct-21-19 07:00AM  AGTC Presents Data Demonstrating Efficiency of its AAV Vectors for Ocular Gene Therapy Even in the Presence of Anti-AAV Antibodies GlobeNewswire -5.19%
Oct-01-19 07:30AM  AGTC and Otonomy Announce Strategic Collaboration to Develop and Commercialize Gene Therapy for Congenital Hearing Loss GlobeNewswire
Sep-30-19 09:29PM  Edited Transcript of AGTC earnings conference call or presentation 26-Sep-19 8:30pm GMT Thomson Reuters StreetEvents
12:03PM  Applied Genetic Notches Sell-Side Upgrade After Releasing Interim Study Data Benzinga
Sep-26-19 05:35PM  Applied Genetic Technologies (AGTC) Reports Q4 Loss, Lags Revenue Estimates Zacks +5.82%
04:01PM  AGTC Announces Financial Results and Business Update for the Fourth Quarter and Fiscal Year Ended June 30, 2019 GlobeNewswire
02:30PM  Applied Genetic Technologies Corp. to Host Earnings Call ACCESSWIRE
Sep-25-19 04:05PM  AGTC to Present at Upcoming Conferences GlobeNewswire
Sep-19-19 10:30AM  Analysts Estimate Applied Genetic Technologies (AGTC) to Report a Decline in Earnings: What to Look Out for Zacks -5.00%
Sep-18-19 04:05PM  AGTC to Host Fourth Quarter and Fiscal Year Financial Results Conference Call and Webcast on September 26, 2019 GlobeNewswire
Sep-16-19 06:23AM  How Many Applied Genetic Technologies Corporation (NASDAQ:AGTC) Shares Do Institutions Own? Simply Wall St.
Sep-02-19 10:30AM  Analysts Estimate Applied Genetic Technologies (AGTC) to Report a Decline in Earnings: What to Look Out for Zacks
Aug-28-19 07:00AM  AGTC to Present at Upcoming Conferences GlobeNewswire
Aug-14-19 07:30AM  Italian Achromatopsia Association Increases Global Awareness of Achromatopsia, a Rare Genetic Eye Disease, With an Expedition to Pingelap, the Island of the Color Blind GlobeNewswire
Aug-07-19 07:00AM  AGTC to Present at the Wedbush PacGrow Healthcare Conference on August 14, 2019 GlobeNewswire
Jul-24-19 01:54PM  Alexion (ALXN) Q2 Earnings Beat Estimates, Guidance Raised Zacks
Jul-23-19 07:00AM  AGTC Completes Enrollment of Third Group in the Dose Escalation Portion of the Achromatopsia CNGA3 Phase 1/2 Clinical Study GlobeNewswire
Jul-19-19 09:41AM  Horizon's NDA for Procysbi New Dosage Form Accepted by FDA Zacks
Jul-17-19 03:33PM  Is Applied Genetic Technologies Corporation (NASDAQ:AGTC) Overpaying Its CEO? Simply Wall St.
Jul-11-19 09:05AM  Horizon Therapeutics Files BLA to FDA for Eye Disease Drug Zacks
Jul-10-19 05:53PM  Mirati Inks Deal with Novartis to Evaluate Tumor Candidate Zacks
05:51PM  Kadmon Initiates Dosing in Study for Systemic Sclerosis Drug Zacks
Jul-08-19 06:02PM  ObsEva Ends Recruitment in Second Uterine Fibroids Study Zacks
Jul-05-19 12:04PM  Catalyst Pharma Focuses on Firdapse Launch & Label Expansion Zacks
Jun-28-19 10:10AM  Novavax (NVAX) Seeks Accelerated Approval Pathway for NanoFlu Zacks
Jun-25-19 08:00AM  Alnylam Presents New Data for RNAi Therapeutic Onpattro Zacks
07:00AM  AGTC Announces New Leadership Appointments GlobeNewswire
Jun-24-19 05:53PM  Epizyme Announces Positive Interim Data on Lead Candidate Zacks
05:45PM  AMAG's Vyleesi Gets FDA NOD for Women with Low Sexual Desire Zacks
Jun-20-19 09:01AM  Ultragenyx & Arcturus Therapeutics Expand Existing Agreement Zacks
Jun-18-19 07:00AM  AGTC to Present at BMO Capital Markets 2019 Prescriptions for Success Healthcare Conference on June 25, 2019 GlobeNewswire
Jun-17-19 06:17PM  Alexion's (ALXN) PNH Drug Ultomiris Shows Long-Term Efficacy Zacks
Jun-14-19 05:25PM  Dr. Reddy's Inks Deal to Sell Neurology Branded Products Zacks
Jun-13-19 05:46PM  Catalyst Pharma Files Lawsuit Against FDA Approval of Ruzurgi Zacks
10:26AM  Alkermes Initiates Monothearpy Expansion Phase of ALKS 4230 Zacks
09:30AM  Is Applied Genetic Technologies (AGTC) Stock Outpacing Its Medical Peers This Year? Zacks
Jun-11-19 06:18PM  Novavax' Shares Drop as FDA Advises Another Study for Resvax Zacks
Jun-04-19 04:16PM  bluebird's Zynteglo Gets EU Conditional Marketing Approval Zacks -5.15%
Jun-03-19 04:48PM  Alnylam Initiates Phase I Study on Hypertension Candidate Zacks +6.30%
May-29-19 10:40AM  Mallinckrodt to Spin Off Specialty Generics Unit, Shares Down Zacks
May-28-19 09:02AM  Epizyme (EPZM) Shares Surge More Than 100% YTD: Here's Why? Zacks
May-27-19 05:00AM  Dynavax (DVAX) to Cut Jobs and Focus on Vaccine Business Zacks
May-24-19 10:53AM  Agenus' (AGEN) Pipeline Progression on Track Amid Competition Zacks
May-23-19 02:25PM  Affimed (AFMD) Earnings and Sales Exceed Estimates in Q1 Zacks
May-20-19 03:06PM  Dr. Reddy's (RDY) Q4 Earnings Up Y/Y, Revenues Top Estimates Zacks
May-19-19 10:25PM  Edited Transcript of AGTC earnings conference call or presentation 7-May-19 12:00pm GMT Thomson Reuters StreetEvents
May-07-19 08:45AM  Applied Genetic Technologies (AGTC) Q3 Earnings and Revenues Surpass Estimates Zacks
07:33AM  Applied Genetic Technologies: Fiscal 3Q Earnings Snapshot Associated Press
07:00AM  AGTC Announces Financial Results and Business Update for the Quarter Ended March 31, 2019 GlobeNewswire
Apr-30-19 07:00AM  AGTC to Host Third Quarter Financial Results Conference Call and Webcast on May 7, 2019 GlobeNewswire
Apr-09-19 09:00AM  Applied Genetic Technologies (AGTC) Upgraded to Strong Buy: What Does It Mean for the Stock? Zacks
Apr-08-19 07:00AM  AGTC Announces Reaching Enrollment Milestones in Phase 1/2 Clinical Trials GlobeNewswire
Apr-03-19 03:20PM  What Kind Of Investor Owns Most Of Applied Genetic Technologies Corporation (NASDAQ:AGTC)? Simply Wall St.
Mar-06-19 05:00AM  Applied Genetic Technologies- An Eye on Optogenetics MoneyShow
Feb-26-19 09:25AM  Will Applied Genetic Technologies Continue to Surge Higher? Zacks
Feb-11-19 09:14AM  Edited Transcript of AGTC earnings conference call or presentation 7-Feb-19 1:00pm GMT Thomson Reuters StreetEvents
Feb-07-19 08:24AM  Applied Genetic Technologies: Fiscal 2Q Earnings Snapshot Associated Press
07:00AM  AGTC Announces Financial Results and Business Update for the Quarter Ended December 31, 2018 GlobeNewswire
Feb-01-19 10:30AM  Analysts Estimate Applied Genetic Technologies (AGTC) to Report a Decline in Earnings: What to Look Out for Zacks
Jan-02-19 07:30AM  New Research: Key Drivers of Growth for Hewlett Packard Enterprise, Micron Technology, Cirrus Logic, Applied Genetic Technologies, KemPharm, and Communications Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire +6.43%
Dec-21-18 12:04PM  Applied Genetic Technologies Corporation (NASDAQ:AGTC): Time For A Financial Health Check Simply Wall St. -13.31%
Dec-19-18 04:38PM  Edited Transcript of AGTC earnings conference call or presentation 8-Nov-18 1:00pm GMT Thomson Reuters StreetEvents
Dec-14-18 07:30AM  Applied Genetic Technologies Enters Oversold Territory Zacks -6.34%
Dec-13-18 01:40PM  Sell-Side Roundup: What's Next For For Applied Genetic After 50% Plunge? Benzinga -47.10%
07:56AM  The Daily Biotech Pulse: Vivus Extends Supply Deal With Sandoz, Applied Genetic Snaps Ties With Biogen Benzinga
06:55AM  Today's Research Reports on Trending Tickers: Novavax and Applied Genetic Technologies ACCESSWIRE
Dec-12-18 04:01PM  AGTC Announces Topline Interim Six-Month Data from Phase 1/2 X-Linked Retinoschisis Clinical Study; Termination of Biogen Collaboration GlobeNewswire +7.36%
Nov-15-18 08:45AM  Consolidated Research: 2018 Summary Expectations for Tapestry, Mallinckrodt public limited company, Moxian, Applied Genetic Technologies, VistaGen Therapeutics, and Oasis Midstream Partners LP Fundamental Analysis, Key Performance Indications GlobeNewswire
Nov-08-18 08:55AM  Applied Genetic Technologies (AGTC) Tops Q1 Earnings and Revenue Estimates Zacks
07:51AM  Applied Genetic Technologies: Fiscal 1Q Earnings Snapshot Associated Press
07:00AM  AGTC Announces Financial Results and Business Update for the Quarter Ended September 30, 2018 GlobeNewswire
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. The company's advanced product candidates consist of three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials. The company also has initiated one preclinical program in otology and three preclinical programs in targeting central nervous system disorders, including one in adrenoleukodystrophy. Applied Genetic Technologies Corporation has collaboration agreements with Synpromics Limited and University of Florida; Bionic Sight, LLC; and Otonomy, Inc. The company was founded in 1999 and is headquartered in Alachua, Florida.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Krol Patrick Johan Hendrik10% OwnerDec 26Sale5.2481,162425,2891,780,762Dec 30 04:33 PM
Krol Patrick Johan Hendrik10% OwnerNov 19Buy2.792,5447,0981,861,924Nov 26 05:17 PM
Washer Susan B.President and CEOSep 18Option Exercise3.505,70019,95028,408Sep 20 04:22 PM
Koenig ScottDirectorMay 28Option Exercise0.3532,01811,20634,246May 30 04:04 PM